Total Payments
$4,439
2024 Payments
$682.28
Companies
33
Transactions
223
Medicare Patients
4,209
Medicare Billing
$439,282
Payment Breakdown by Category
Food & Beverage$4,361 (98.2%)
Education$78.10 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,361 | 218 | 98.2% |
| Education | $78.10 | 5 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,210 | 53 | $0 (2024) |
| PFIZER INC. | $465.77 | 18 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $350.39 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $344.17 | 19 | $0 (2024) |
| Celgene Corporation | $216.26 | 12 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $212.59 | 14 | $0 (2024) |
| Covidien LP | $164.76 | 3 | $0 (2019) |
| Gilead Sciences, Inc. | $155.31 | 4 | $0 (2024) |
| Daiichi Sankyo Inc. | $153.77 | 10 | $0 (2023) |
| Romark Laboratories, LC | $132.68 | 9 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $682.28 | 35 | ABBVIE INC. ($214.02) |
| 2023 | $699.52 | 37 | AbbVie Inc. ($259.72) |
| 2022 | $522.48 | 24 | ABBVIE INC. ($281.56) |
| 2021 | $413.36 | 21 | Medtronic, Inc. ($116.83) |
| 2020 | $329.39 | 22 | Romark Laboratories, LC ($74.33) |
| 2019 | $876.36 | 35 | AbbVie, Inc. ($196.08) |
| 2018 | $540.98 | 23 | PFIZER INC. ($147.42) |
| 2017 | $374.82 | 26 | AbbVie, Inc. ($124.94) |
All Payment Transactions
223 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $17.45 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $94.42 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $3.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Gastroenterology | ||||||
| 10/17/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.24 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.75 | General |
| 10/01/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.03 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Gastroenterology | ||||||
| 07/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/18/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/10/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.23 | General |
| Category: Neuroscience | ||||||
| 07/02/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Immunology | ||||||
| 06/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Immunology | ||||||
| 06/03/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $13.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: IMMUNOLOGY | ||||||
| 05/17/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,259 | 1,773 | $591,394 | $129,417 |
| 2022 | 19 | 1,149 | 1,454 | $556,001 | $119,656 |
| 2021 | 17 | 956 | 1,125 | $466,504 | $102,816 |
| 2020 | 16 | 845 | 994 | $386,411 | $87,393 |
Total Patients
4,209
Total Services
5,346
Medicare Billing
$439,282
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 128 | 128 | $147,200 | $25,821 | 17.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 142 | 198 | $18,810 | $11,837 | 62.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 122 | 123 | $95,940 | $10,527 | 11.0% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 76 | 193 | $28,950 | $9,366 | 32.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 187 | 379 | $56,850 | $8,860 | 15.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 48 | 48 | $38,400 | $8,499 | 22.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 57 | 57 | $15,105 | $7,673 | 50.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 33 | 33 | $26,400 | $5,917 | 22.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 54 | 54 | $48,600 | $5,626 | 11.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 59 | 79 | $7,900 | $4,896 | 62.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 37 | 37 | $29,600 | $4,876 | 16.5% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 70 | 78 | $13,650 | $4,694 | 34.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 33 | $5,940 | $3,368 | 56.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 71 | $4,353 | $3,309 | 76.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 40 | $5,600 | $3,133 | 56.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 33 | 33 | $23,100 | $2,699 | 11.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 74 | $3,411 | $2,527 | 74.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $5,890 | $2,380 | 40.4% |
| 43450 | Dilation of esophagus | Facility | 2023 | 48 | 50 | $12,500 | $1,519 | 12.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 11 | $1,815 | $1,026 | 56.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 22 | 23 | $1,380 | $862.13 | 62.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 116 | 116 | $133,400 | $23,273 | 17.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 153 | 154 | $113,880 | $14,006 | 12.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 82 | 84 | $25,035 | $12,976 | 51.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 140 | 183 | $19,785 | $11,166 | 56.4% |
About Dr. Erick Salvatierra, MD
Dr. Erick Salvatierra, MD is a Gastroenterology healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508067653.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erick Salvatierra, MD has received a total of $4,439 in payments from pharmaceutical and medical device companies, with $682.28 received in 2024. These payments were reported across 223 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($4,361).
As a Medicare-enrolled provider, Salvatierra has provided services to 4,209 Medicare beneficiaries, totaling 5,346 services with total Medicare billing of $439,282. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Lafayette, LA
- Active Since 05/29/2007
- Last Updated 10/29/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508067653
Products in Payments
- XELJANZ (Drug) $465.77
- SKYRIZI (Biological) $414.41
- STELARA (Biological) $273.81
- RINVOQ (Biological) $208.07
- ZEPOSIA (Drug) $202.84
- Humira (Biological) $197.28
- PillCam (Device) $164.76
- INJECTAFER (Drug) $137.93
- ENTYVIO (Biological) $131.70
- GI Genius (Device) $116.83
- LINZESS (Drug) $111.30
- Epclusa (Drug) $105.73
- TREMFYA (Drug) $94.42
- CREON (Drug) $93.08
- Linzess (Drug) $91.30
- HUMIRA (Biological) $84.27
- XIFAXAN (Drug) $82.29
- REMICADE (Biological) $80.92
- ALINIA (Drug) $74.33
- Entyvio (Biological) $69.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lafayette
Dr. Kerri Glassner, D.o, D.O
Gastroenterology — Payments: $75,707
Gastroenterology $75,707
Dr. Jacob Karr, Md, MD
Gastroenterology — Payments: $42,466
Gastroenterology $42,466
Mr. Jacque Noel, Md, MD
Gastroenterology — Payments: $11,841
Gastroenterology $11,841
Dr. Ramu Raju, Md, MD
Gastroenterology — Payments: $11,609
Gastroenterology $11,609
Dr. Stephen Abshire, Md, MD
Gastroenterology — Payments: $8,695
Gastroenterology $8,695
Jacob Breaux, M.d, M.D
Gastroenterology — Payments: $8,611
Gastroenterology $8,611